Related Experiment Video
Updated: Jun 25, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Contemporary outcomes of acute ischemic stroke in atrial fibrillation patients on anticoagulation
Moises A Vasquez1, Litsa K Lambrakos2, Alex Velasquez2
1Department of Internal Medicine, University of Miami Miller School of Medicine/Jackson Memorial Hospital, 1611 NW 12th Ave, C-600D, Miami, FL 33136, USA.
Long-term anticoagulation (AC) therapy for atrial fibrillation (AF) patients significantly reduces in-hospital mortality and stroke severity. AC use also led to fewer complications and better outcomes for AF patients experiencing ischemic stroke.
Area of Science:
- Cardiology
- Neurology
- Public Health
Background:
- Long-term anticoagulation (AC) therapy is crucial for reducing stroke risk in patients with Atrial Fibrillation (AF).
- Limited data exists on the specific impact of AC on in-hospital stroke outcomes for AF patients.
Purpose of the Study:
- To investigate the association between pre-stroke long-term AC use and in-hospital outcomes in patients with Atrial Fibrillation (AF) and ischemic stroke.
Main Methods:
- Utilized the National Inpatient Sample (NIS) database from 2016-2020.
- Identified adult inpatients with AF and primary ischemic stroke diagnosis.
- Employed multivariate regression to analyze in-hospital outcomes, adjusting for comorbidities, comparing AC users and non-users.
Main Results:
- Included 655,540 hospitalizations; 29.7% were on long-term AC.
- AC use was linked to significantly decreased in-hospital mortality (aOR 0.62).
- AC patients showed reduced stroke severity (NIHSS 8 vs. 10) and fewer complications, including intracranial hemorrhage and GI bleeding.
Conclusions:
- Pre-stroke AC use in AF patients with ischemic stroke is associated with improved in-hospital outcomes.
- AC therapy correlates with lower mortality, reduced stroke severity, and fewer complications.
- Findings suggest the benefit of maintaining AC in AF patients at risk for stroke.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Clot Retraction and Fibrinolysis

